Provided by Tiger Trade Technology Pte. Ltd.

POINT BIOPHARMA GLOBAL INC

12.50
0.0000
Volume:- -
Turnover:41.13M
Market Cap:1.33B
PE:13.92
High:12.50
Open:12.50
Low:12.50
Close:12.50
52wk High:14.35
52wk Low:6.39
Shares:106.57M
Float Shares:70.03M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8979
EPS(LYR):1.04
ROE:26.33%
ROA:16.77%
PB:3.14
PE(LYR):12.03

Loading ...

Feb 07, 2023

Major Issues Report

8-K - Current report
Nov 22, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 26, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 26, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 16, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 14, 2022

Major Issues Report

8-K - Current report
Sep 13, 2022

Major Issues Report

8-K - Current report
Sep 12, 2022

Major Issues Report

8-K - Current report
Sep 06, 2022

Major Issues Report

8-K - Current report
Aug 29, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 07, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jun 03, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2022

Major Issues Report

8-K - Current report
Mar 25, 2022

Major Issues Report

8-K - Current report
Mar 25, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]